CLINICAL TRIAL: LIOTHYRONINE (T3) STUDY FOR BIPOLAR DEPRESSION

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是确定利托洛宁(T3)治疗8周对双相情感障碍患者抑郁评分的影响，作为常规治疗的增强策略。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The aim of this study is to determine the effects on depression scores of 8-weeks of treatment with liothyronine (T3) as an augmentation strategy to treatment as usual for patients with bipolar disorder.